Development Level

Tbio 2 | 11,445
Tclin 2 | 613
Tchem 1 | 1,598
Tdark 1 | 6,588

IMPC Phenotype

abnormal gait 1 | 69
embryonic lethality prior to t... 1 | 278
preweaning lethality, complete... 1 | 979

Disease

Carcinoma 6 | 11,493
psoriasis 5 | 6,694
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,291
non-small cell lung cancer 4 | 2,890
osteosarcoma 4 | 7,950
Atherosclerosis 3 | 291
Cancer 3 | 2,499
Diabetes Mellitus, Experimental 3 | 108
Diabetes Mellitus, Non-Insulin-Dependent 3 | 145
Diabetes Mellitus, Type 2 3 | 142
Fatty liver disease 3 | 103
Heart disease 3 | 306
Hyperglycemia 3 | 137
Insulin Resistance 3 | 72
Obesity 3 | 678
Schizophrenia 3 | 1,160
diabetes mellitus 3 | 1,728
ductal carcinoma in situ 3 | 1,745
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
invasive ductal carcinoma 3 | 2,951
lung adenocarcinoma 3 | 2,716
lung cancer 3 | 4,740
medulloblastoma, large-cell 3 | 6,241
ulcerative colitis 3 | 1,819
Autosomal recessive predisposition 2 | 1,442
Coronary artery disease 2 | 268
Crohn Disease 2 | 45
Diabetic dyslipidemia associated with type 2 diabetes mellitus 2 | 2
Dyslipidemias 2 | 27
Heart failure 2 | 162
Hepatomegaly 2 | 285
Hypercholesterolemia 2 | 44
Hyperinsulinism 2 | 133
Hypertension 2 | 396
Hypertensive disease 2 | 292
Hypertrophic Cardiomyopathy 2 | 117
Hypoglycemia 2 | 152
Inflammation 2 | 120
Lipid metabolism disorder 2 | 114
Liver disease 2 | 237
Liver neoplasms 2 | 130
Nerve Degeneration 2 | 121
Parkinson's disease 2 | 392
Reperfusion Injury 2 | 86
breast carcinoma 2 | 1,638
glioblastoma 2 | 5,792
group 3 medulloblastoma 2 | 4,104
interstitial cystitis 2 | 2,312
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
pediatric high grade glioma 2 | 1,064
pituitary cancer 2 | 1,972
posterior fossa group B ependymoma 2 | 416
primitive neuroectodermal tumor 2 | 3,035
tuberculosis 2 | 2,010
Abnormality of the musculature 1 | 16
Acanthosis Nigricans 1 | 27
Acute Lung Injury 1 | 22
Barrett Esophagus 1 | 16
Chondrosarcoma 1 | 21
Congenital anomaly of neck 1 | 19
Decreased subcutaneous adipose tissue 1 | 13
Deformity of neck 1 | 19
Endometrial stromal nodule 1 | 11
Familial partial lipodystrophy 1 | 12
Fatigable weakness of respiratory muscles 1 | 28
Fatigable weakness of swallowing muscles 1 | 28
Glomerulonephritis 1 | 46
High density lipoprotein decreased 1 | 10
Hyperplasia of supraorbital ridge 1 | 19
Hypertriglyceridemia result 1 | 37
Hypertrophy of supraorbital margins 1 | 19
Hypertrophy of supraorbital ridge 1 | 19
Hypoalphalipoproteinemias 1 | 10
Ischemia 1 | 28
Kidney Failure, Chronic 1 | 46
Large hand 1 | 18
Lipidoses 1 | 19
Lipodystrophy 1 | 40
Lipoidosis 1 | 19
Lymphoma, T-Cell 1 | 13
Malformation of the neck 1 | 19
Multiple carboxylase deficiency 1 | 7
Muscle Cramp 1 | 55
Myocardial Reperfusion Injury 1 | 37
Myoepithelioma 1 | 13
Neoplasms 1 | 63
Oligomenorrhea 1 | 16
Pain 1 | 103
Papillary thyroid carcinoma 1 | 43
Polycystic Kidney, Autosomal Dominant 1 | 7
Primary Prevention of Coronary Heart Disease 1 | 4
Primary physiologic amenorrhea 1 | 55
Prominent supraorbital ridges 1 | 19
Short chain acyl-CoA dehydrogenase deficiency 1 | 9
Skeletal muscle hypertrophy 1 | 16
Steatohepatitis 1 | 44
T-Cell Lymphoma 1 | 13
Thyroid Neoplasms 1 | 34
Xerostomia 1 | 42

Tissue

Blood and immune system 6 | 16,909
Cardiovascular System 6 | 15,192
Digestive Tract 6 | 17,369
Endocrine System 6 | 18,159
Female tissues 6 | 17,400
Liver and Pancreas 6 | 16,750
Male tissues 6 | 17,142
Nervous System 6 | 16,725
Respiratory system 6 | 16,393
Skin and soft tissues 6 | 17,230
Urinary Tract 6 | 16,678

Target Family

Nuclear Receptor 3 | 48
Non-IDG 2 | 12,091
Enzyme 1 | 4,145

GO Process

positive regulation of fatty a... 6 | 6
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Malonyl-CoA decarboxylase, mitochondrial MLYCD Tchem Enzyme -1.70434 46.1 67
Nuclear receptor subfamily 4 group A member 3 NR4A3 Tbio Nuclear Receptor -2.02752 112.7 289
Complement C1q tumor necrosis factor-related protein 2 C1QTNF2 Tdark Non-IDG -0.36938 3.10 225
Peroxisome proliferator-activated receptor gamma PPARG Tclin Nuclear Receptor -3.96393 9579.5 773
Peroxisome proliferator-activated receptor alpha PPARA Tclin Nuclear Receptor -3.37176 2457.9 501
Peroxisome proliferator-activated receptor gamma coactivator 1-alpha PPARGC1A Tbio Non-IDG -2.86449 728.1 274